Inovio Pharmaceuticals (INO) Reports Mixed Q3 Results

Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q3 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $2.64 million versus the consensus estimate of $1.87 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• H.C. Wainwright Reiterates Neutral Rating on Inovio Pharmaceuticals (INO)
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Jefferies Upgrades Inovio Pharmaceuticals (INO) to Buy